My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 103

    1.

    Effects of bevacizumab on retinal function in isolated vertebrate retina.

    Lüke M, Warga M, Ziemssen F, Gelisken F, Grisanti S, Schneider T, Lüke C, Partsch M, Bartz-Schmidt KU, Szurman P; Tuebingen Bevacizumab Study Group.

    Br J Ophthalmol. 2006 Sep;90(9):1178-82. Epub 2006 Jun 5.PMID: 16754646 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The retinal tolerance to bevacizumab in co-application with a recombinant tissue plasminogen activator.

    Lüke M, Januschowski K, Warga M, Beutel J, Leitritz M, Gelisken F, Grisanti S, Schneider T, Lüke C, Bartz-Schmidt KU, Szurman P; for the Tuebingen Bevacizumab Study Group.

    Br J Ophthalmol. 2007 Aug;91(8):1077-82. Epub 2007 Mar 23.PMID: 17383998 [PubMed - indexed for MEDLINE]Related articles

    3.

    The effects of ranibizumab (Lucentis) on retinal function in isolated perfused vertebrate retina.

    Lüke M, Januschowski K, Lüke J, Peters S, Wirtz N, Yörük E, Lüke C, Bartz-Schmidt KU, Grisanti S, Szurman P.

    Br J Ophthalmol. 2009 Oct;93(10):1396-400. Epub 2009 Jul 23.PMID: 19628500 [PubMed - indexed for MEDLINE]Related articles

    4.

    Effects of protein tyrosine kinase inhibitor genistein on retinal function in superfused vertebrate retina.

    Lüke C, Krott R, Lüke M, Lebek J, Walter P, Brunner R, Sickel W.

    J Ocul Pharmacol Ther. 2001 Apr;17(2):151-8.PMID: 11324982 [PubMed - indexed for MEDLINE]Related articles

    5.

    The effects of triamcinolone crystals on retinal function in a model of isolated perfused vertebrate retina.

    Lüke M, Januschowski K, Beutel J, Warga M, Grisanti S, Peters S, Schneider T, Lüke C, Bartz-Schmidt KU, Szurman P.

    Exp Eye Res. 2008 Jul;87(1):22-9. Epub 2008 Apr 23.PMID: 18514644 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effects of the protein tyrosine kinase inhibitor genistein and taurine on retinal function in isolated superfused retina.

    Lüke M, Krott R, Warga M, Szurman P, Grisanti S, Bartz-Schmidt KU, Schneider T, Lüke C.

    Graefes Arch Clin Exp Ophthalmol. 2007 Feb;245(2):242-8.PMID: 16453129 [PubMed - indexed for MEDLINE]Related articles

    7.

    Safety monitoring in bevacizumab (Avastin) treatment: retinal function assessed by psychophysical (visual fields, colour vision) and electrophysiological (ERG/EOG) tests in two subgroups of patients.

    Ziemssen F, Lüke M, Messias A, Beutel J, Tatar O, Zrenner E, Bartz-Schmidt KU; Tuebingen Bevacizumab Study Group.

    Int Ophthalmol. 2008 Apr;28(2):101-9. Epub 2007 Jul 20.PMID: 17634860 [PubMed - indexed for MEDLINE]Related articles

    8.

    Bevacizumab (avastin) does not harm retinal function after intravitreal injection as shown by electroretinography in adult mice.

    Heiduschka P, Julien S, Hofmeister S, Bartz-Schmidt KU, Schraermeyer U.

    Retina. 2008 Jan;28(1):46-55.PMID: 18185137 [PubMed - indexed for MEDLINE]Related articles

    9.

    The effects of the phosphodiesterase type V inhibitor sildenafil on human and bovine retinal function in vitro.

    Lüke M, Szurman P, Schneider T, Lüke C.

    Graefes Arch Clin Exp Ophthalmol. 2007 Aug;245(8):1211-5.PMID: 17345091 [PubMed - indexed for MEDLINE]Related articles

    10.

    Effects of phosphodiesterase type 5 inhibitor sildenafil on retinal function in isolated superfused retina.

    Lüke M, Lüke C, Hescheler J, Schneider T, Sickel W.

    J Ocul Pharmacol Ther. 2005 Aug;21(4):305-14.PMID: 16117694 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effects of bevacizumab (Avastin) on retinal cells in organotypic culture.

    Kaempf S, Johnen S, Salz AK, Weinberger A, Walter P, Thumann G.

    Invest Ophthalmol Vis Sci. 2008 Jul;49(7):3164-71. Epub 2008 Mar 14.PMID: 18344448 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Electrophysiological effects of Brilliant Blue G in the model of the isolated perfused vertebrate retina.

    Lüke M, Januschowski K, Beutel J, Lüke C, Grisanti S, Peters S, Jaissle GB, Bartz-Schmidt KU, Szurman P.

    Graefes Arch Clin Exp Ophthalmol. 2008 Jun;246(6):817-22. Epub 2008 Jan 16.PMID: 18197412 [PubMed - indexed for MEDLINE]Related articles

    13.

    Effect of anti-VEGF antibody on retinal ganglion cells in rats.

    Iriyama A, Chen YN, Tamaki Y, Yanagi Y.

    Br J Ophthalmol. 2007 Sep;91(9):1230-3. Epub 2007 May 2.PMID: 17475701 [PubMed - indexed for MEDLINE]Related articles

    14.

    Evaluation of in vitro effects of bevacizumab (Avastin) on retinal pigment epithelial, neurosensory retinal, and microvascular endothelial cells.

    Luthra S, Narayanan R, Marques LE, Chwa M, Kim DW, Dong J, Seigel GM, Neekhra A, Gramajo AL, Brown DJ, Kenney MC, Kuppermann BD.

    Retina. 2006 May-Jun;26(5):512-8.PMID: 16770256 [PubMed - indexed for MEDLINE]Related articles

    15.

    Are intravitreal bevacizumab and ranibizumab effective in a rat model of choroidal neovascularization?

    Lu F, Adelman RA.

    Graefes Arch Clin Exp Ophthalmol. 2009 Feb;247(2):171-7. Epub 2008 Sep 10.PMID: 18781316 [PubMed - indexed for MEDLINE]Related articles

    16.

    Effects of daunorubicin and CD95L on retinal function in superfused vertebrate retina.

    Hueber A, Lüke M, Esser PJ, Kirchhof B, Sickel W, Lüke C.

    J Ocul Pharmacol Ther. 2005 Apr;21(2):133-8.PMID: 15857279 [PubMed - indexed for MEDLINE]Related articles

    17.

    Effects of patent blue on human retinal function.

    Lüke C, Lüke M, Sickel W, Schneider T.

    Graefes Arch Clin Exp Ophthalmol. 2006 Sep;244(9):1188-90. Epub 2006 Feb 17.PMID: 16485112 [PubMed - indexed for MEDLINE]Related articles

    18.

    Electrophysiologic and retinal penetration studies following intravitreal injection of bevacizumab (Avastin).

    Shahar J, Avery RL, Heilweil G, Barak A, Zemel E, Lewis GP, Johnson PT, Fisher SK, Perlman I, Loewenstein A.

    Retina. 2006 Mar;26(3):262-9.PMID: 16508424 [PubMed - indexed for MEDLINE]Related articles

    19.

    Intravitreal bevacizumab (Avastin) for occult choroidal neovascularization in age-related macular degeneration.

    Aisenbrey S, Ziemssen F, Völker M, Gelisken F, Szurman P, Jaissle G, Grisanti S, Bartz-Schmidt KU.

    Graefes Arch Clin Exp Ophthalmol. 2007 Jul;245(7):941-8. Epub 2006 Dec 21.PMID: 17186262 [PubMed - indexed for MEDLINE]Related articles

    20.

    Retinal tolerance to dyes.

    Lüke C, Lüke M, Dietlein TS, Hueber A, Jordan J, Sickel W, Kirchhof B.

    Br J Ophthalmol. 2005 Sep;89(9):1188-91.PMID: 16113379 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity